Health Literacy in Medicines Use and Pharmacy: A Definitive Guide highlights issues related to the medication literacy from the context of pharmacist and other healthcare professionals. This book provides a clear explanation of medication literacy, presents different tools to assess health literacy, readability, and comprehensibility of written medicine information (WMI), elaborates on different approaches to develop customized and patient-friendly WMI, and assists in the global effort for harmonization and availability of quality WMI. Written by experts in medical communication, this book will help pharmacists, other health professionals, educators, and regulators who may be ill-equipped to develop customized education material and provide effective medication literacy information, especially for patients with low health literacy.
Table of Contents
1. Introduction to Medication Literacy and Health Literacy in Pharmacy2. Assessment of Health Literacy
3. Global initiatives for promotion of medication literacy
4. Written medicine information
5. Pharmaceutical pictograms
6. The use of information technology in medication literacy
7. Approaching patients with low health literacy to improve communication and outcomes Communication strategies
8. Promoting health literacy practices in pharmacy through quality improvement
9. Health literacy issues in community pharmacy setting
10. Health literacy issues in pediatrics and their caregivers
11. Perspectives of prescribers towards medication literacy issues in tertiary care setting
12. User testing as a tool to improve medication literacy
13. Health Literacy Pharmacy Education: Developing Medication Literacy Curriculum
14. Advancing Pharmacy Research on Health Literacy
15. Establishment of a multidisciplinary medicines information network
16. Medical Interpreters Training for health care professionals
Authors
Ahmed Awaisu Associate Professor of Clinical Pharmacy and Practice, College of Pharmacy, Qatar University, Qatar. Dr. Ahmed Awaisu received his Bachelor of Pharmacy degree from Ahmadu Bello University Zaria, Nigeria in 1999, his masters and Ph.D degrees in Clinical Pharmacy from Universiti Sains Malaysia (USM) in 2004 and 2009, respectively. He is also a licensed pharmacist and has practiced in the hospital setting since 1999. Dr. Awaisu has a unique privilege of past academic experiences in international pharmacy degree programs. He has made substantial and tremendous contributions that impact teaching and learning, research, curriculum design, as well as professional development of students and healthcare practitioners in Qatar and other countries. He received the "Qatar University Merit Award for Outstanding Faculty� for 2016-2017 Academic Year. He is a member of the American College of Clinical Pharmacy (ACCP), the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), among others. Emad Eldin Munsour Emad Eldin Munsour is a supervisor in the Pharmacy and Drug Control department at the Ministry of Public Health. Emad Eldin Munsour holds a master degree in Pharmacy practice and has around 16 years in pharma-regulatory and compliance area. He looks after the authorization of pharmaceutical products, including evaluation of bioequivalence studies, clinical trials, and Pharmacovigilance system, in addition to CMC (Chemistry, Manufacturing, and Controls).Emad is the editor of Qatar National Formulary (QNF) and is a professional reviewer for the WHO bulletin and Value in Health Regional issues. He is also involved in many projects related to Qatar National Health Strategy (NHS) i.e. National Drug Coding, Generic use and advancement of the pharmaceutical legislative framework. He shared his research in various international conferences and published some articles on pharmaceutical care and other pharmacy practice areas. Rabia Hussain Universiti Sains Malaysia, Malaysia.Dr. Rabia Hussain Ph.D. is a Senior Lecturer at the School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia. Her research focuses on medication safety and pharmacovigilance in low and middle-income countries (LMICs). She has extensively published on pharmacovigilance, pharmacy practice research methods, issues related to medicines use, and clinical pharmacy. She has published in journals including The Lancet, Research in Social and Administrative Pharmacy, International Journal of Clinical Pharmacy, Journal of Pharmaceutical Policy and Practice, Journal of Public Health, Vaccines, Health and Quality of Life Outcomes, The Journal of Allergy & Clinical Immunology: In Practice and International Journal of Environmental Research and Public Health, while the book chapters are in Elsevier and Springer books on pharmacy such as "Encyclopaedia of Pharmacy Practice and Clinical Pharmacy� and "Pharmaceutical Policy in Countries with developing health systems�. She also worked with the ReAct - Action on Antibiotic Resistance, Uppsala University, Sweden on "improving the use of antibiotics�. Dr. Hussain is the Section Editor of Journal of Pharmaceutical Policy and Practice (JoPPP), editorial board member of Research in Social and Administrative Pharmacy and academic editor for Plos One. Her edited work includes "Encyclopaedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy (Elsevier)� and "Health Literacy in Medicines Use and Pharmacy: A Definitive Guide, (Elsevier)�.
Zaheer-Ud-Din Babar Professor in Medicines and Healthcare and Director, Centre of Pharmaceutical Policy and Practice Research, University of Huddersfield, UK. Professor Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare and the Director of Centre of Pharmaceutical Policy and Practice Research at the University of Huddersfield, United Kingdom. He is globally known for his work in pharmaceutical policy and practice, including quality use of medicines, clinical pharmacy practice, access to medicines and issues related to pharmacoeconomics.He has published in high impact journals such as PLoS Medicine and the Lancet and has acted as a consultant for World Health Organization, Royal Pharmaceutical Society, Health Action International, International Union Against Tuberculosis and Lung Disease, World Bank, European Union, International Pharmaceutical Federation (FIP) and for the Pharmaceutical Management Agency of New Zealand.
His edited work includes "Economic evaluation of pharmacy services", "Pharmaceutical prices in the 21st century�, "Pharmaceutical policies in countries with developing healthcare systems ", "Global Pharmaceutical Policy�, "Pharmacy Practice Research Methods� and "Encyclopedia of Pharmacy Practice and Clinical Pharmacy�. Published by Elsevier and Adis/Springer, the work is used in curriculum design, policy development and for referral all around the globe.
Professor Babar is also the Editor-in-Chief of BMC Journal of Pharmaceutical Policy and Practice and can be contacted at z.babar@hud.ac.uk Parisa Aslani Professor in Medicines Use Optimisation, The University of Sydney, Australia. Professor Parisa Aslani, Professor in Medicines Use Optimisation, The University of Sydney, NSW 2006. She is a co-chair of Curriculum Review for the BPharm and MPharm degrees. Expert advisor to staff regarding teaching and learning matters. For example, the development of oral examination rubrics for MPharm UoS PHAR5716 and PHAR5717. Director of Academic Career Development (School of Pharmacy), Faculty of Medicine and Health (0.5 FTE). Vice-President, International Pharmaceutical Federation (FIP) (since 2020).
